Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
To integrate the two advantages of upregulated stability during blood circulation and site-specific drug release in cancer cells, pH/reduction dual-responsive prodrug microspheres with high drug content were designed by conjugating doxorubicin (DOX) onto aldehyde-functionalized disulfide-crosslinked copolymer microspheres via acid-labile imine linkage, where the copolymer microspheres were synthesized by facile emulsion copolymerization of poly(ethylene glycol) methyl ether methacrylate (PEGMA) and 4-formylphenyl acrylate (FPA) with N,N-bis(acryloyl)cystamine (BACy) as crosslinker. Their particle size and average hydrodynamic diameter were 150nm and 205nm respectively, with high DOX content of 44.4%. The DOX release ratio reached 73% within 60h and the prodrug microspheres decrosslinked into water soluble copolymers within 72h in the simulated tumor microenvironment (pH5.0 with 10mM GSH), while only 16% of DOX was released in physiological medium (pH7.4 with 10μM GSH), demonstrating their good tumor intracellular triggered release performance. Furthermore, the disintegration of the copolymer microspheres into water soluble copolymers in simulated tumor microenvironment would favor the metabolism of drug carriers. The MTT assay demonstrated that the prodrug microspheres exhibited the enhanced inhibitory efficiency against HepG2 cells in comparison with free DOX, while the bare polymer microspheres were cytocompatible.
[Display omitted]
•Novel monomer, 4-formylphenyl acrylate (FPA) was synthesized.•Facile method was developed for pH/reductant dual-responsive prodrug microspheres.•High DOX content of 44.4% was achieved.•Prodrug microspheres can disintegrate within 72h in simulated tumor microenvironment.